Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection
New Zealand
781602
Filed on 2021-10-22
781602
Filed on 2021-10-22
Antibodies Targeting The Spike Protein Of Coronaviruses
Patent Cooperation Treaty
PCT/US2022/015341
Filed on 2022-02-04
PCT/US2022/015341
Filed on 2022-02-04
TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION
Mexico
MX/a/2021/012384
Filed on 2020-04-08
MX/a/2021/012384
Filed on 2020-04-08
TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION
Philippines
1-2021-500042
Filed on 2020-04-08
1-2021-500042
Filed on 2020-04-08
TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION
Israel
286932
Filed on 2020-04-08
286932
Filed on 2020-04-08
Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use
Patent Cooperation Treaty
PCT/US2022/012530
Filed on 2022-01-14
PCT/US2022/012530
Filed on 2022-01-14
NANOPARTICLE-BASED INFLUENZA VIRUS VACCINES AND USES THEREOF
Hong Kong
62022053678.8
Filed on 2020-02-07
62022053678.8
Filed on 2020-02-07
USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
European Patent
21180582.5
Filed on 2021-06-21
21180582.5
Filed on 2021-06-21
NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE
US Patent 12,043,660
Filed on 2021-12-14
Filed on 2021-12-14